RACHEL KATTER: Open Payments
NPI 1013596337 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 47 payments from 16 companies in 2025. Trend: 2023 $501 · 2024 $846 · 2025 $1,477
Food & beverage: $1,284Education: $193
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $323 |
| Daiichi Sankyo Inc. | 11 | $256 |
| Gilead Sciences, Inc. | 3 | $195 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Lilly USA, LLC | 3 | $146 |
| Merck Sharp & Dohme LLC | 2 | $60 |
| Stemline Therapeutics Inc. | 2 | $53 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $41 |
| TerSera Therapeutics LLC | 2 | $41 |
Products named: RYBREVANT, Trodelvy, Enhertu, ERLEADA, KISQALI, DATROWAY, KEYTRUDA, Orserdu.
Industry payments across VA — which companies pay providers there.
